| Literature DB >> 33321877 |
Paweł Gutaj1, Rafał Sibiak1,2, Maurycy Jankowski3, Karina Awdi4, Rut Bryl3, Paul Mozdziak5, Bartosz Kempisty2,3,6,7, Ewa Wender-Ozegowska1.
Abstract
Adipocytokines are hormonally active molecules that are believed to play a key role in the regulation of crucial biological processes in the human body. Numerous experimental studies established significant alterations in the adipokine secretion patterns throughout pregnancy. The exact etiology of various gestational complications, such as gestational diabetes, preeclampsia, and fetal growth abnormalities, needs to be fully elucidated. The discovery of adipokines raised questions about their potential contribution to the molecular pathophysiology of those diseases. Multiple studies analyzed their local mRNA expression and circulating protein levels. However, most studies report conflicting results. Several adipokines such as leptin, resistin, irisin, apelin, chemerin, and omentin were proposed as potential novel early markers of heterogeneous gestational complications. The inclusion of the adipokines in the standard predictive multifactorial models could improve their prognostic values. Nonetheless, their independent diagnostic value is mostly insufficient to be implemented into standard clinical practice. Routine assessments of adipokine levels during pregnancy are not recommended in the management of both normal and complicated pregnancies. Based on the animal models (e.g., apelin and its receptors in the rodent preeclampsia models), future implementation of adipokines and their receptors as new therapeutic targets appears promising but requires further validation in humans.Entities:
Keywords: adiponectin; apelin; chemerin; gestational diabetes; irisin; leptin; omentin; preeclampsia; resistin; visfatin
Year: 2020 PMID: 33321877 PMCID: PMC7762997 DOI: 10.3390/ijms21249408
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923